Delivery Order SPE2DB25D3020-SPE2DB25FWKTM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets (60-count packages) with a ceiling value of $2,869.54. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.03 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER 10 mg tablets. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,327.10 delivery order contract is for the supply of 30mg Oxymorphone HCL ER tablets, a pain management medication. The contract has an August 2023 completion date and is a firm fixed-price arrangement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Troop Support Medical awarded a $5,158.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for oxymorphone hydrochloride extended release tablets. Under the contract, Amerisourcebergen will deliver 20 milligram oxymorphone hydrochloride extended release tablets to a location in Conshohocken, Pennsylvania by June 29, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will perform the order itself without involvement from major...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKTMDelivery Order
The Defense Logistics Agency awarded a $2,981.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count) on September 19, 2025, with completion targeted for September 22, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor vehicle valued through December 2026 that authorizes AmerisourceBergen to supply comprehensive pharmaceutical and medical supply solutions to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company maintains a robust portfolio of delivery orders encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for controlled pharmaceutical products reflects the company's ongoing role in supplying essential medications to military and veteran healthcare systems through competitive, firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/19/25 |